Finanzwire Finanzwire
Basculer en Français
10900 Companies
237596 Keywords
166538 Articles
127636 Press releases
Headlines Articles Press releases Guangzhou Wanglaoji Pharmaceutical Company Remove
  1. Home
  2. Companies
  3. Guangzhou Wanglaoji Pharmaceutical Company
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/07/2024 at 18:05, 2 years 3 months ago

    Launch of WALOVI's international identity by Wanglaoji in Paris during the Sino-French Gastronomic Festival

    International Market Wanglaoji WALOVI Sino-French Gastronomic Festival Chinese Herbal Tea
  • BRIEF

    published on 05/07/2024 at 10:05, 2 years 3 months ago

    Wanglaoji Launches WALOVI Brand at Sino-French Food Carnival in Paris

    Cultural Exchange Wanglaoji WALOVI Herbal Tea Sino-French Relations
  • PRESS RELEASE

    published on 05/07/2024 at 10:00, 2 years 3 months ago

    Enjoy the taste of spring together and convey good wishes—— Wanglaoji showed up at the 'Sino-French Food Carnival' and Launched the International Brand Identity WALOVI in Paris

    Sino-French Food Carnival celebrates 60th anniversary of China-France relations on Seine River. Wanglaoji introduces herbal tea brand WALOVI to overseas markets with focus on healthy consumption trend
    Wanglaoji Herbal Tea Sino-French Food Carnival Overseas Market Healthy Consumption
    Logo of Guangzhou Wanglaoji Pharmaceutical Company
Accesswire
  • Published on 08/31/2026 at 17:22, 4 hours 20 minutes ago

    ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison

  • Published on 08/31/2026 at 15:50, 5 hours 52 minutes ago

    Sarama Resources - Grant of Equity Incentives

  • Published on 08/31/2026 at 15:00, 6 hours 42 minutes ago

    Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available

  • Published on 08/31/2026 at 14:30, 7 hours 12 minutes ago

    Boron One Holdings Inc. Project Update

  • Published on 08/31/2026 at 14:30, 7 hours 12 minutes ago

    While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

View all ACCESSWIRE
EQS Group
  • Published on 08/31/2026 at 19:31, 2 hours 11 minutes ago

    DEAG reports strong results for the first half of 2026

  • Published on 08/31/2026 at 19:15, 2 hours 27 minutes ago

    CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region

  • Published on 08/31/2026 at 18:20, 3 hours 22 minutes ago

    CPI PROPERTY GROUP publishes financial results for the first half of 2026

  • Published on 08/31/2026 at 18:06, 3 hours 36 minutes ago

    MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026

  • Published on 08/31/2026 at 18:04, 3 hours 38 minutes ago

    PRIMARY HYDROGEN EXPANDS CUMBERLAND BASIN POSITION WITH STAKING OF THE WALLACE PROJECT, NOVA SCOTIA

View all EQS
Les Echos
  • Published on 08/31/2026 at 17:45, 3 hours 57 minutes ago

    Disclosure of transactions in own shares from August 24 to August 28, 2026

  • Published on 08/31/2026 at 17:45, 3 hours 57 minutes ago

    Weekly share buyback

  • Published on 08/31/2026 at 12:00, 9 hours 42 minutes ago

    Capital increase through exercise of subscription rights

  • Published on 08/31/2026 at 07:00, 14 hours 42 minutes ago

    Biophytis strengthens its financial position and extends its cash runway into Q1 2027

  • Published on 08/28/2026 at 06:55, 3 days 14 hours ago

    Recticel Accelerates Profitable Growth

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy